Aurobindo, others recall products in US market over production issue: USFDA

Drug makers Aurobindo Pharma, Glenmark and FDC are recalling products in the US due to manufacturing issues, as per the US Food and Drug Administration (USFDA).

Aurobindo Pharma USA Inc -- a unit of Hyderabad-based drug major -- is recalling 240 bottles of pain-relieving medication Healthy Living Acetaminophen, Aspirin (NSAID) and caffeine tablets.

As per the latest enforcement report of USFDA, the company is recalling the affected lot due to "Missing Label".

Some bottles are missing the manufacturer's label that includes the drug facts information, the US health regulator said.

The New Jersey-based Aurobindo Pharma USA Inc initiated the Class 1 recall on July 11, it said.

As per the US health regulator, a Class I recall pertains to defective products that can cause serious health problems.

Similarly, a US-based subsidiary of Glenmark Pharmaceuticals is recalling 2,404 bottles of Indomethacin Extended-Release Capsules, produced at a Madhya Pradesh plant, due to "Failed Dissolutio